Literature DB >> 32276758

Management of Challenging Cardiopulmonary Bypass Separation.

Fabrizio Monaco1, Ambra Licia Di Prima2, Jun Hyun Kim3, Marie-Jo Plamondon4, Andrey Yavorovskiy5, Valery Likhvantsev6, Vladimir Lomivorotov7, Ludhmila Abrahão Hajjar8, Giovanni Landoni9, H Riha10, A M G A Farag11, G Gazivoda12, F S Silva13, C Lei14, N Bradic15, M R El-Tahan16, N A R Bukamal17, L Sun18, C Y Wang19.   

Abstract

SEPARATION from cardiopulmonary bypass (CPB) after cardiac surgery is a progressive transition from full mechanical circulatory and respiratory support to spontaneous mechanical activity of the lungs and heart. During the separation phase, measurements of cardiac performance with transesophageal echocardiography (TEE) provide the rationale behind the diagnostic and therapeutic decision-making process. In many cases, it is possible to predict a complex separation from CPB, such as when there is known preoperative left or right ventricular dysfunction, bleeding, hypovolemia, vasoplegia, pulmonary hypertension, or owing to technical complications related to the surgery. Prompt diagnosis and therapeutic decisions regarding mechanical or pharmacologic support have to be made within a few minutes. In fact, a complex separation from CPB if not adequately treated leads to a poor outcome in the vast majority of cases. Unfortunately, no specific criteria defining complex separation from CPB and no management guidelines for these patients currently exist. Taking into account the above considerations, the aim of the present review is to describe the most common scenarios associated with a complex CPB separation and to suggest strategies, pharmacologic agents, and para-corporeal mechanical devices that can be adopted to manage patients with complex separation from CPB. The routine management strategies of complex CPB separation of 17 large cardiac centers from 14 countries in 5 continents will also be described.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  anesthesia; cardiopulmonary bypass; discontinuation; inotropes; intensive care; separation; ventricular dysfunction; weaning

Mesh:

Year:  2020        PMID: 32276758     DOI: 10.1053/j.jvca.2020.02.038

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  4 in total

1.  Cardiovascular Consequences and Considerations of Coronavirus Infection - Perspectives for the Cardiothoracic Anesthesiologist and Intensivist During the Coronavirus Crisis.

Authors:  John G Augoustides
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-04-09       Impact factor: 2.628

2.  Calcium administration In patients undergoing CardiAc suRgery under cardiopulmonary bypasS (ICARUS trial): Rationale and design of a randomized controlled trial.

Authors:  Vladimir Lomivorotov; Dmitry Ponomarev; Vladimir Boboshko; Vladimir Shmyrev; Samandar Ismoilov; Sergey Efremov; Nikolay Kamenshchikov; Boris Akselrod; Vadim Pasyuga; Dmitry Urusov; Alexey Ovezov; Mikhail Evdokimov; Alexander Turchaninov; Alexander Bogachev-Prokofiev; Nazar Bukamal; Sarah Afifi; Alessandro Belletti; Rinaldo Bellomo; Giovanni Landoni
Journal:  Contemp Clin Trials Commun       Date:  2021-08-18

3.  Prolonged mechanical ventilation after cardiac surgery: substudy of the Transfusion Requirements in Cardiac Surgery III trial.

Authors:  Ashwin Sankar; Alexandra J Rotstein; Bijan Teja; François Martin Carrier; Emilie P Belley-Côté; Daniel Bolliger; Tarit Saha; Paula Carmona; Michael Sander; Nadine Shehata; Kevin E Thorpe; C David Mazer
Journal:  Can J Anaesth       Date:  2022-09-19       Impact factor: 6.713

4.  Massive pulmonary embolism and thrombus-in-transit via a patent foramen ovale: a case report of successful use of extracorporeal membrane oxygenation to manage post-embolectomy severe right ventricular dysfunction.

Authors:  Helen Saunders; Abdulwahab Al Khalifa; Angel Espinosa; Manish Jain
Journal:  Eur Heart J Case Rep       Date:  2021-04-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.